Novel Thrombolytic Drug Based on Thrombin Cleavable Microplasminogen Coupled to a Single-Chain Antibody Specific for Activated GPIIb/IIIa
Thomas Bonnard, Zachary Tennant, Be'Eri Niego, Ruchi Kanojia, Karen Alt, Shweta Jagdale, Lok Soon Law, Sheena Rigby, Robert Lindsay Medcalf, Karlheinz Peter, Christoph Eugen Hagemeyer
Journal of the American Heart Association | WILEY-BLACKWELL | Published : 2017
Awarded by People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme (FP7) under REA grant
Awarded by National Heart Foundation of Australia
Awarded by German Research Foundation
This work was funded by the National Health and Medical Research Council (NHMRC). Bonnard has received funding from the People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme (FP7/2007-2013) under REA grant agreement No. 608765, Niego is supported by a postdoctoral fellowship from the National Heart Foundation of Australia (award No. 100906). Alt was supported by the German Research Foundation (Al 1521/1-1), Peter is a Principal Research Fellow of the NHMRC, and Hagemeyer is a National Heart Foundation Career Development Fellow. The work was also supported in part by the Victorian Government's Operational Infrastructure Support Program and Victoria's Science Agenda Strategic Project Fund.